Company / Operating Margin
Kura Oncology, Inc. Operating Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-449.9%
FY2025
5-year range
-449.9% / -358.6%
FY2024-FY2025
Trend
-25.5%
vs FY2024
Sector context
#109 of 136
Health Care
What the data says
Kura Oncology, Inc.'s operating margin of -449.9% is lower than 80% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
-449.9% in FY2025.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 136This company -449.9% Sector average -778.9%
▼
+42.2% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 25.5% year-over-year.
- Currently 329.0pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -449.9% | -25.5% |
| FY2024 | -358.6% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026